These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 16982418)

  • 1. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited neuropathies: new genes don't fit old models.
    Scherer SS
    Neuron; 2006 Sep; 51(6):672-4. PubMed ID: 16982409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
    Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
    Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.
    Abe A; Hayasaka K
    J Hum Genet; 2009 May; 54(5):310-2. PubMed ID: 19329989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
    He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
    Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.
    Sivakumar K; Kyriakides T; Puls I; Nicholson GA; Funalot B; Antonellis A; Sambuughin N; Christodoulou K; Beggs JL; Zamba-Papanicolaou E; Ionasescu V; Dalakas MC; Green ED; Fischbeck KH; Goldfarb LG
    Brain; 2005 Oct; 128(Pt 10):2304-14. PubMed ID: 16014653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
    Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
    Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect.
    Nangle LA; Zhang W; Xie W; Yang XL; Schimmel P
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11239-44. PubMed ID: 17595294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.
    Dubourg O; Azzedine H; Yaou RB; Pouget J; Barois A; Meininger V; Bouteiller D; Ruberg M; Brice A; LeGuern E
    Neurology; 2006 Jun; 66(11):1721-6. PubMed ID: 16769947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.
    Sleigh JN; Grice SJ; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2014 May; 23(10):2639-50. PubMed ID: 24368416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
    Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
    Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.
    Spaulding EL; Sleigh JN; Morelli KH; Pinter MJ; Burgess RW; Seburn KL
    J Neurosci; 2016 Mar; 36(11):3254-67. PubMed ID: 26985035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
    Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
    J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.